Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder

NCT03395314 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03395314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Terminated
Start date
February 15, 2018
Completion date
May 6, 2022
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder